AAAAAA
Results:
1-17
|
Results: 17
Authors:
Tripodis, N
Hart, AAM
Fijneman, RJA
Demant, P
Citation: N. Tripodis et al., Complexity of lung cancer modifiers: Mapping of thirty genes and twenty-five interactions in half of the mouse genome, J NAT CANC, 93(19), 2001, pp. 1484-1491
Authors:
Pajukanta, P
Bodnar, JS
Sallinen, R
Chu, M
Airaksinen, T
Xiao, QN
Castellani, LW
Sheth, SS
Wessman, M
Palotie, A
Sinsheimer, JS
Demant, P
Lusis, AJ
Peltonen, L
Citation: P. Pajukanta et al., Fine mapping of Hyplip1 and the human homolog, a potential locus for FCHL, MAMM GENOME, 12(3), 2001, pp. 238-245
Authors:
Tripodis, N
Demant, P
Citation: N. Tripodis et P. Demant, Three-dimensional patterns of lung tumor growth: Association with tumor heterogeneity, EXP LUNG R, 27(6), 2001, pp. 521-531
Authors:
Tripodis, N
Demant, P
Citation: N. Tripodis et P. Demant, Genetic linkage of nuclear morphology of mouse lung tumors to the Kras-2 locus, EXP LUNG R, 27(3), 2001, pp. 185-196
Authors:
Wandersee, NJ
Roesch, AN
Hamblen, NR
de Moes, J
van der Valk, MA
Bronson, RT
Gimm, JA
Mohandas, N
Demant, P
Barker, JE
Citation: Nj. Wandersee et al., Defective spectrin integrity and neonatal thrombosis in the first mouse model for severe hereditary elliptocytosis, BLOOD, 97(2), 2001, pp. 543-550
Authors:
Sundberg, JP
Boggess, D
Shultz, LD
Fijneman, RJA
Demant, P
Hogenesch, H
Cox, GA
Citation: Jp. Sundberg et al., The chronic proliferative dermatitis mouse mutation (cpdm): mapping of themutant gene locus, J EXP ANIM, 41(3), 2000, pp. 101-108
Authors:
Holan, V
Havelkova, H
Krulova, M
Demant, P
Lipoldova, M
Citation: V. Holan et al., A novel alloreactivity-controlling locus, Alan1, mapped to mouse Chromosome 17, IMMUNOGENET, 51(8-9), 2000, pp. 755-757
Authors:
Sitarz, M
Wirth-Dzieciolowska, E
Demant, P
Citation: M. Sitarz et al., Loss of heterozygosity on chromosome 5 in vicinity of the telomere in gamma-radiation-induced thymic lymphomas in mice, NEOPLASMA, 47(3), 2000, pp. 148-150
Authors:
Kramnik, I
Dietrich, WF
Demant, P
Bloom, BR
Citation: I. Kramnik et al., Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis, P NAS US, 97(15), 2000, pp. 8560-8565
Authors:
Bloom, BR
Mazzaccaro, RJ
Flynn, JA
Chan, J
Sousa, A
Salgame, P
Stenger, S
Modlin, RL
Krensky, A
Demant, P
Kramni, I
Citation: Br. Bloom et al., Immunology of an infectious disease: Pathogenesis and protection in tuberculosis, IMMUNOLOGIS, 7(1-2), 1999, pp. 54-59
Authors:
Mori, N
Yamate, J
Stassen, APM
Oka, S
Okumoto, H
Tsubura, A
Akamatsu, T
Sakuma, S
Demant, P
Citation: N. Mori et al., Modulations of glucocorticoid-induced apoptosis linked to the p53 deletionand to the apoptosis susceptibility gene Rapop1 (Radiation-induced apoptosis 1), ONCOGENE, 18(29), 1999, pp. 4282-4285
Authors:
Havelkova, H
Kosarova, M
Krulova, M
Demant, P
Lipoldova, M
Citation: H. Havelkova et al., T-cell proliferative response is controlled by loci Tria4 and Tria5 on mouse Chromosomes 7 and 9, MAMM GENOME, 10(7), 1999, pp. 670-674
Authors:
Havelkova, H
Kosarova, M
Krulova, M
Holan, V
Demant, P
Lipoldova, M
Citation: H. Havelkova et al., T-cell proliferative response is controlled by locus Tria3 on mouse chromosome 17, IMMUNOGENET, 49(3), 1999, pp. 235-237
Authors:
Kosarova, M
Havelkova, H
Krulova, M
Demant, P
Lipoldova, M
Citation: M. Kosarova et al., The production of two Th2 cytokines, interleukin-4 and interleukin-10, is controlled independently by locus Cypr1 and by loci Cypr2 and Cypr3, respectively, IMMUNOGENET, 49(2), 1999, pp. 134-141
Authors:
Szymanska, H
Sitarz, M
Krysiak, E
Piskorowska, J
Czarnomska, A
Skurzak, H
Hart, AAM
de Jong, D
Demant, P
Citation: H. Szymanska et al., Genetics of susceptibility to radiation-induced lymphomas, leukemias and lung tumors studied in recombinant congenic strains, INT J CANC, 83(5), 1999, pp. 674-678
Authors:
van Wezel, T
Ruivenkamp, CAL
Stassen, APM
Moen, CJA
Demant, P
Citation: T. Van Wezel et al., Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse, CANCER RES, 59(17), 1999, pp. 4216-4218
Authors:
Burn, J
Alonso, A
Bertario, L
Bishop, T
Bisgaard, ML
Cummings, J
Davidson, R
Delhanty, J
Demant, P
Dunlop, M
Eccles, D
Ellis, A
Evans, G
Fidalgo, P
Fodde, R
Haites, N
Hodgson, S
Hultcrantz, R
Huson, S
Jarvinen, H
Kartheuser, A
Kleibeuker, J
Lenaerts, C
Lucasson, A
Lunt, P
McDermot, K
McKay, J
McKeown, C
Maher, E
Mathers, J
Mecklin, JP
Moslein, G
Murday, V
Nagengast, F
Northover, JMA
Obrador, A
Parks, TG
Paraskeva, C
Phillips, R
San Roman, C
Ruscheoff, J
Sampson, J
Shepherd, N
Tempesta, A
Trembath, R
Turnpenny, P
Vasen, HFA
Citation: J. Burn et al., Concerted action polyp prevention, CAPP2: A trial of aspirin and/or resistant starch in people at risk of hereditary non-polyposis colon cancer (HNPCC), BIOM HLTH R, 24, 1998, pp. 17-23
Risultati:
1-17
|